Hyperbilirubinemia

Critical Care Nursing Clinics of North America

Volumn 21, Issue 1, 2009, Pages 97-120

  Watson, Robin L ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Exchange transfusion; Hyperbilirubinemia; Jaundice; Kernicterus; Phototherapy

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN;

BIOSYNTHESIS; BREAST FEEDING; EXCHANGE BLOOD TRANSFUSION; FETUS; GESTATIONAL AGE; HUMAN; KERNICTERUS; METABOLISM; METHODOLOGY; MONITORING; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; NEWBORN NURSING; NEWBORN SCREENING; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; PHOTOTHERAPY; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

BILIRUBIN; BREAST FEEDING; EXCHANGE TRANSFUSION, WHOLE BLOOD; FETUS; GESTATIONAL AGE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; KERNICTERUS; MONITORING, PHYSIOLOGIC; NEONATAL NURSING; NEONATAL SCREENING; NURSE'S ROLE; NURSING ASSESSMENT; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 60449115232     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2008.11.001     Document Type: Review

References (150)

1. Watchko J.F. Neonatal hyperbilirubinemia: what are the risks?. N Engl J Med 354 18 (2006) 1947-1949
2. Maisels M.J., and McDonagh A.F. Phototherapy for neonatal jaundice. N Engl J Med 358 9 (2008) 920-928
3. Bhutani V.K., Johnson L.H., and Keren R. Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am 51 4 (2004) 843-861 vii
4. Vreman H.J., Wong R.J., and Stevenson D.K. Phototherapy: current methods and future directions. Semin Perinatol 28 5 (2004) 326-333
5. American Academy of Pediatrics Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics 94 4 Pt 1 (1994) 558-565
6. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114(1):297-316.
7. The Joint Commission. Kernicterus threatens healthy newborns: sentinel event alert. Available at: http://www.jointcommission.org/SentinelEvents/SentinelEventAler t/sea_18.htm. Accessed June 12, 2008.
8. The Joint Commission. Revised guidance to help prevent kernicterus: sentinel event alert. Available at: http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_31. htm. Accessed June 12, 2008.
9. Maisels M.J. Jaundice. In: MacDonald M.G., Mullett M.D., and Seshia M.M.K. (Eds). Avery's neonatology: pathophysiology & management of the newborn. 6th edition (2005), Lippincott Williams & Wilkins, Philadelphia 768-846
10. Wong R.J., DeSandre G.H., Sibley E., et al. Neonatal jaundice and liver disease. In: Martin R.J., Fanaroff A.A., and Walsh M.C. (Eds). Fanaroff and Martin's neonatal-perinatal medicine: diseases of the fetus and infant. 8th edition (2006), Mosby Elsevier, Philadelphia 1419-1465
11. Wong R.J., Stevenson D.K., Ahlfors C.E., et al. Neonatal jaundice: bilirubin physiology and clinical chemistry. NeoReviews 8 (2007) e58-e67. http://neoreviews.aappublications.org/cgi/content/full/neoreviews;8/2/e5 8 Accessed June 27, 2008
12. Blackburn S.T. Bilirubin metabolism. Maternal, fetal, neonatal physiology: a clinical perspective. 2nd edition (2003), WB Saunders, St. Louis (MO) 652-676
13. Gartner L.M. Neonatal jaundice. Pediatr Rev 15 11 (1994) 422-432
14. Bartoletti A.L., Stevenson D.K., Ostrander C.R., et al. Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production. I. Effects of gestational and postnatal age and some common neonatal abnormalities. J Pediatr 94 6 (1979) 952-955
15. Maisels M.J., Pathak A., Nelson N.M., et al. Endogenous production of carbon monoxide in normal and erythroblastic newborn infants. J Clin Invest 50 1 (1971) 1-8
16. Maden A., MacMahon J.R., and Stevenson D.K. Neonatal hyperbilirubinemia. In: Taeusch H.W., Ballard R.A., and Gleason C.A. (Eds). Avery's diseases of the newborn. 8th edition (2005), Elsevier Saunders, Philadelphia 1226-1256
17. Notarianni L.J. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharm 18 1 (1990) 20-36
18. Wolkoff A.W., Goresky C.A., Sellin J., et al. Role of ligandin in transfer of bilirubin from plasma into liver. Am J Phys 236 6 (1979) E638-E648
19. Onishi S., Kawade N., Itoh S., et al. Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver. Biochem J 184 3 (1979) 705-707
20. Kawade N., and Onishi S. The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 196 1 (1981) 257-260
21. Gartner L.M. On the question of the relationship between breastfeeding and jaundice in the first 5 days of life. Semin Perinatol 18 6 (1994) 502-509
22. Gourley G.R. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol 7 2 (2002) 135-141
23. Boyer D.B., and Vidyasagar D. Serum indirect bilirubin levels and meconium passage in early fed normal newborns. Nurse Res 36 3 (1987) 174-178
24. Maisels M.J. What's in a name? Physiologic and pathologic jaundice: the conundrum of defining normal bilirubin levels in the newborn. Pediatrics 118 2 (2006) 805-807
25. Hardy R.C., Drage J.S., and Jackson E.C. The first year of life: the collaborative perinatal project of the National Institutes of Neurological and Communicative Disorders and Stroke (1979), John Hopkins University Press, Baltimore (MD)
26. Maisels M.J., and Kring E. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of > or = 35 weeks' gestation. Pediatrics 117 4 (2006) 1169-1173
27. Bhutani V.K., Johnson L., and Sivieri E.M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103 1 (1999) 6-14
28. Newman T.B., Escobar G.J., Gonzales V.M., et al. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics 104 5 Pt 2 (1999) 1198-1203
29. Maisels M.J., Fanaroff A.A., Stevenson D.K., et al. Serum bilirubin levels in an international, multiracial newborn population. Pediatr Res 45 4 Pt 2 (1999) 167A
30. Juretschke L.J. Kernicterus: still a concern. Neonatal Netw 24 2 (2005) 7-19
31. Maisels M.J. Neonatal hyperbilirubinemia. In: Klaus M.H., and Fanaroff A.A. (Eds). Care of the high-risk neonate. 5th edition (2001), WB Saunders Company, Philadelphia 324-362
32. Saigal S., Lunyk O., Bennett K.J., et al. Serum bilirubin levels in breast- and formula-fed infants in the first 5 days of life. Can Med Assoc J 127 10 (1982) 985-989
33. Okolo A.A., Omene J.A., and Scott-Emuakpor A.B. Physiologic jaundice in the Nigerian neonate. Biol Neonate 53 3 (1988) 132-137
34. Maisels M.J., and Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics 99 4 (1997) 599-601
35. de Almeida M.F., and Draque C.M. Neonatal jaundice and breastfeeding. NeoReviews 8 7 (2007) e282-e288. http://neoreviews.aappublications.org/cgi/content/full/neoreviews;8/7/e2 82 Accessed June 27, 2008
36. Maisels M.J. Neonatal jaundice. Pediatr Rev 27 12 (2006) 443-454
37. Maisels M.J., and Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics 78 5 (1986) 837-843
38. Schneider A.P. Breast milk jaundice in the newborn: a real entity. JAMA 255 23 (1986) 3270-3274
39. Jaundice. Centers for Disease Control and Prevention Web site. Available at:. http://www.cdc.gov/breastfeeding/disease/jaundice.htm Accessed June 21, 2008
40. Fevery J. Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology 113 5 (1997) 1798-1800
41. Gartner U., Goeser T., and Wolkoff A.W. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology 113 5 (1997) 1707-1713
42. De Carvalho M., Robertson S., and Klaus M. Fecal bilirubin excretion and serum bilirubin concentrations in breast-fed and bottle-fed infants. J Pediatr 107 5 (1985) 786-790
43. Yamauchi Y., and Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics 86 2 (1990) 171-175
44. De Carvalho M., Klaus M.H., and Merkatz R.B. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child 136 8 (1982) 737-738
45. Yoshioka H., Iseki K., and Fujita K. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72 3 (1983) 317-321
46. Frank C.G., and Frank P.H. Jaundice. In: Merenstein G.B., and Gardner L.S. (Eds). Handbook of neonatal intensive care. 6th edition (2006), Mosby Elsevier, St. Louis (MO) 548-568
47. Kernicterus in full-term infants: United States, 1994-1998. MMWR Morb Mortal Wkly Rep 50 23 (2001) 491-494
48. Kaplan M., and Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a worldwide potential cause of severe neonatal hyperbilirubinemia. NeoReviews 1 (2000) e32-e39. http://neoreviews.aappublications.org/cgi/content/full/neoreviews;1/2/e3 2 Accessed June 27, 2008
49. Kaplan M., and Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus. Semin Perinatol 28 5 (2004) 356-364
50. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ 67 (1989) 610-611
51. Johnson L.H., Bhutani V.K., and Brown A.K. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 140 4 (2002) 396-403
52. Cashore W.J. Bilirubin metabolism and toxicity in the newborn. In: Polin R.A., Fox W.W., and Abman S.H. (Eds). Fetal and neonatal physiology. 3rd edition (2004), Saunders, Philadelphia 1199-1210
53. Fox I.J., Chowdhury J.R., Kaufman S.S., et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338 20 (1998) 1422-1426
54. Chowdhury J.R., Chowdhury N.R., Strom S.C., et al. Human hepatocyte transplantation: gene therapy and more?. Pediatrics 102 3 Pt 1 (1998) 647-648
55. Rubaltelli F.F., Guerrini P., Reddi E., et al. Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics 84 4 (1989) 728-731
56. Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics 113 1 Pt 1 (2004) 119-123
57. Van der Veere C.N., Jansen P.L., Sinaasappel M., et al. Oral calcium phosphate: a new therapy for Crigler-Najjar disease?. Gastroenterology 112 2 (1997) 455-462
58. Bancroft J.D., Kreamer B., and Gourley G.R. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 132 4 (1998) 656-660
59. Laforgia N., Faienza M.F., Rinaldi A., et al. Neonatal hyperbilirubinemia and Gilbert's syndrome. J Perinat Med 30 2 (2002) 166-169
60. Venigalla S., and Gourley G.R. Neonatal cholestasis. Semin Perinatol 28 5 (2004) 348-355
61. McLin V.A., and Balistreri W.F. Approach to neonatal cholestasis. In: Walker W.A., Goulet O., Kleinman R.E., et al (Eds). Pediatric gastrointestinal disease: pathophysiology, diagnosis, management. 4th edition (2004), BC Decker, Inc., Hamilton (Ontario, Canada) 1079-1093
62. McKiernan P.J. Neonatal cholestasis. Semin Neonatol 7 2 (2002) 153-165
63. Schmorl G. Zur kenntnis des ikterus neonatorum, insbesondere der dabei auftretenden gehirnveranderungen. [German]. Verh Dtsch Ges Pathol 6 (1904) 109-115
64. Johnson L., Brown A.K., and Bhutani V.K. Bind: a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics 104 (1999) 746-747
65. Ip S., Chung M., Kulig J., et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 114 1 (2004) e130-e153
66. Andersen D.H., Blanc W.A., and Crozier D.N. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18 4 (1956) 614-625
67. Odell G.B. Studies in kernicterus. I. The protein binding of bilirubin. J Clin Invest 38 5 (1959) 823-833
68. Jardine D.S., and Rogers K. Relationship of benzyl alcohol to kernicterus, intraventricular hemorrhage, and mortality in preterm infants. Pediatrics 83 2 (1989) 153-160
69. Volpe J.J. Bilirubin and brain injury. Neurology of the newborn. 4th edition (2000), WB Saunders Company, Philadelphia 521-564
70. Dennery P.A., Seidman D.S., and Stevenson D.K. Neonatal hyperbilirubinemia. N Engl J Med 344 8 (2001) 581-590
71. Newman T.B., Liljestrand P., Jeremy R.J., et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354 18 (2006) 1889-1900
72. Penn A.A., Enzmann D.R., Hahn J.S., et al. Kernicterus in a full term infant. Pediatrics 93 6 Pt 1 (1994) 1003-1006
73. Maisels M.J., and Newman T.B. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics 96 4 Pt 1 (1995) 730-733
74. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 89 10 (2000) 1213-1217
75. Govaert P., Lequin M., Swarte R., et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 112 6 Pt 1 (2003) 1256-1263
76. Slusher T.M., Vreman H.J., McLaren D.W., et al. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 126 1 (1995) 102-108
77. Murki S., Kumar P., Majumdar S., et al. Risk factors for kernicterus in term babies with non-hemolytic jaundice. Indian Pediatr 38 7 (2001) 757-762
78. Nair P.A.K., and Al Khussiby S.M. Kernicterus and G6PD deficiency: a case series from Oman. J Trop Pediatr 49 (2003) 74-77
79. Stanley T.V. A case of kernicterus in New Zealand: a predictable tragedy?. J Paediatr Child Health 33 (1997) 451-453
80. Watchko J.F. Vigintiphobia revisited. Pediatrics 115 6 (2005) 1747-1753
81. Eaton A.P. Early postpartum discharge: recommendations from a preliminary report to Congress. Pediatrics 107 2 (2001) 400-403
82. Li R., Zhao Z., Mokdad A., et al. Prevalence of breastfeeding in the United States: the 2001 national immunization survey. Pediatrics 111 5 Part 2 (2003) 1198-1201
83. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics 108 3 (2001) 763-765
84. Gartner L.M., Snyder R.N., Chabon R.S., et al. Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics 45 6 (1970) 906-917
85. Watchko J.F., and Oski F.A. Kernicterus in preterm newborns: past, present, and future. Pediatrics 90 5 (1992) 707-715
86. Watchko J.F., and Maisels M.J. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed 88 6 (2003) F455-F458
87. Maisels M.J., and Watchko J.F. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 88 6 (2003) F459-F463
88. National Institute of Child Health and Human Development. Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia: executive summary. Pediatrics 75 2 Pt 2 (1985) 385-386
89. Kramer L.I. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 118 3 (1969) 454-458
90. Johnson L., and Bhutani V.K. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 25 3 (1998) 555-574 viii
91. Moyer V.A., Ahn C., and Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med 154 4 (2000) 391-394
92. Sykes E., and Epstein E. Laboratory measurement of bilirubin. Clin Perinatol 17 2 (1990) 397-416
93. Doumas B.T., and Wu T.W. The measurement of bilirubin fractions in serum. Crit Rev Clin Lab Sci 28 5-6 (1991) 415-445
94. Vreman H.J., Verter J., Oh W., et al. Interlaboratory variability of bilirubin measurements. Clin Chem 42 6 Pt 1 (1996) 869-873
95. Doumas B.T., and Eckfeldt J.H. Errors in measurement of total bilirubin: a perennial problem. Clin Chem 42 6 Pt 1 (1996) 845-848
96. Lo S.F., Doumas B.T., and Ashwood E.R. Performance of bilirubin determinations in US laboratories: revisited. Clin Chem 50 1 (2004) 190-194
97. Gourley G.R. Bilirubin metabolism and kernicterus. Adv Pediatr 44 (1997) 173-229
98. Eidelman A.I., Schimmel M.S., Algur N., et al. Capillary and venous bilirubin values: they are different-and how!. Am J Dis Child 143 6 (1989) 642
99. Leslie G.I., Philips III J.B., and Cassady G. Capillary and venous bilirubin values: are they really different?. Am J Dis Child 141 11 (1987) 1199-1200
100. Ahlfors C.E. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 93 3 (1994) 488-494
101. Ahlfors C.E., and Wennberg R.P. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol 28 (2004) 334-339
102. Wennberg R.P., Ahlfors C.E., Bhutani V.K., et al. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 117 2 (2006) 474-485
103. Amin S.B. Clinical assessment of bilirubin-induced neurotoxicity in premature infants. Semin Perinatol 28 5 (2004) 340-347
104. McDonagh A.F., and Maisels M.J. Bilirubin unbound: deja vu all over again?. Pediatrics 117 2 (2006) 523-525
105. Hanko E. Unbound bilirubin and risk assessment in the jaundiced newborn: possibilities and limitations. Pediatrics 117 2 (2006) 526-527
106. Blackmon L.R., Fanaroff A.A., and Raju T.N. Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development conference executive summary, 2003. Pediatrics 114 1 (2004) 229-233
107. Grohmann K., Roser M., Rolinski B., et al. Bilirubin measurement for neonates: comparison of 9 frequently used methods. Pediatrics 117 4 (2006) 1174-1183
108. Bhutani V.K., Gourley G.R., Adler S., et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 106 2 (2000) E17. http://pediatrics.aappublications.org/cgi/reprint/106/2/e17 Accessed June 12, 2008
109. Briscoe L., Clark S., and Yoxall C.W. Can transcutaneous bilirubinometry reduce the need for blood tests in jaundiced full term babies?. Arch Dis Child Fetal Neonatal Ed 86 3 (2002) F190-F192
110. Ebbesen F., Rasmussen L.M., and Wimberley P.D. A new transcutaneous bilirubinometer, bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr 91 2 (2002) 203-211
111. Rubaltelli F.F., Gourley G.R., Loskamp N., et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics 107 6 (2001) 1264-1271
112. Yasuda S., Itoh S., Isobe K., et al. New transcutaneous jaundice device with two optical paths. J Perinat Med 31 1 (2003) 81-88
113. Maisels M.J., Ostrea Jr. E.M., Touch S., et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics 113 6 (2004) 1628-1635
114. Slusher T.M., Angyo I.A., Bode-Thomas F., et al. Transcutaneous bilirubin measurements and serum total bilirubin levels in indigenous African infants. Pediatrics 113 6 (2004) 1636-1641
115. Engle W.D., Jackson G.L., Sendelbach D., et al. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics 110 1 Pt 1 (2002) 61-67
116. Jaundice meter JM-103 [product catalogue]. Konica Minolta Web site. Available at:. http://www.konicaminolta.com/instruments/download/catalog/medical/pdf/jm 103_e7.pdf Accessed July 2, 2008
117. Stevenson D.K., Fanaroff A.A., Maisels M.J., et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 108 1 (2001) 31-39
118. Newman T.B., Xiong B., Gonzales V.M., et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 11 (2000) 1140-1147
119. Maisels M.J., and Kring E. Length of stay, jaundice, and hospital readmission. Pediatrics 101 6 (1998) 995-998
120. Keren R., Luan X., Friedman S., et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 121 1 (2008) e170-e179
121. Cremer R.J., Perryman P.W., and Richards D.H. Influence of light on the hyperbilirubinaemia of infants. Lancet 1 7030 (1958) 1094-1097
122. Maisels M.J., Kring E.A., and DeRidder J. Randomized controlled trial of light-emitting diode phototherapy. J Perinatol 27 9 (2007) 565-567
123. Tan K.L. The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinaemia. Pediatr Res 16 8 (1982) 670-674
124. Tan K.L. Phototherapy for neonatal jaundice. Clin Perinatol 18 3 (1991) 423-439
125. Holtrop P.C., Ruedisueli K., and Maisels M.J. Double versus single phototherapy in low birth weight newborns. Pediatrics 90 5 (1992) 674-677
126. Tan K.L. Comparison of the efficacy of fiberoptic and conventional phototherapy for neonatal hyperbilirubinemia. J Pediatr 125 4 (1994) 607-612
127. Maisels M.J. A primer on phototherapy for the jaundiced newborn. Contemp Pediatr 22 6 (2005) passim. 38,40,44,47,48,53,54,57
128. Stokowski L.A. Fundamentals of phototherapy for neonatal jaundice. Adv Neonatal Care 6 6 (2006) 303-312
129. Mills J.F., and Tudehope D. Fibreoptic phototherapy for neonatal jaundice. NICHD Cochrane neonatal Web site. Available at:. http://www.nichd.nih.gov/cochrane/Mills/Review.htm Accessed July 2, 2008
130. Tonz O., Vogt J., Filippini L., et al. [Severe light dermatosis following photo therapy in a newborn infant with congenital erythropoietic urophyria]. Helv Paediatr Acta 30 1 (1975) 47-56 German
131. Kearns G.L., Williams B.J., and Timmons O.D. Fluorescein phototoxicity in a premature infant. J Pediatr 107 5 (1985) 796-798
132. Pezzati M., Fusi F., Dani C., et al. Changes in skin temperature of hyperbilirubinemic newborns under phototherapy: conventional versus fiberoptic device. Am J Perinatol 19 8 (2002) 439-444
133. Dollberg S., Atherton H.D., and Hoath S.B. Effect of different phototherapy lights on incubator characteristics and dynamics under three modes of servocontrol. Am J Perinatol 12 1 (1995) 55-60
134. Grunhagen D.J., de Boer M.G., de Beaufort A.J., et al. Transepidermal water loss during halogen spotlight phototherapy in preterm infants. Pediatr Res 51 3 (2002) 402-405
135. Maayan-Metzger A., Yosipovitch G., Hadad E., et al. Transepidermal water loss and skin hydration in preterm infants during phototherapy. Am J Perinatol 18 7 (2001) 393-396
136. Csoma Z., Kemeny L., and Olah J. Phototherapy for neonatal jaundice. N Engl J Med 358 23 (2008) 2523-2524
137. Csoma Z., Hencz P., Orvos H., et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 119 6 (2007) 1036-1037
138. Garg A.K., Prasad R.S., and Hifzi I.A. A controlled trial of high-intensity double-surface phototherapy on a fluid bed versus conventional phototherapy in neonatal jaundice. Pediatrics 95 6 (1995) 914-916
139. Hansen T.W. Acute management of extreme neonatal jaundice: the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 86 8 (1997) 843-846
140. Maisels M.J., and Kring E. Rebound in serum bilirubin level following intensive phototherapy. Arch Pediatr Adolesc Med 156 7 (2002) 669-672
141. Kaplan M., Kaplan E., Hammerman C., et al. Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child 91 1 (2006) 31-34
142. Steiner L.A., Bizzarro M.J., Ehrenkranz R.A., et al. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 120 1 (2007) 27-32
143. Maisels M.J. Phototherapy: traditional and nontraditional. J Perinatol 21 Suppl 1 (2001) S93-S97
144. Rubo J., Albrecht K., Lasch P., et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 121 1 (1992) 93-97
145. Dagoglu T., Ovali F., Samanci N., et al. High dose intravenous immunoglobulin therapy for haemolytic disease. J Int Med Res 23 4 (1995) 264-271
146. Voto L.S., Sexer H., Ferreiro G., et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 23 6 (1995) 443-451
147. Hammermann C., and Kaplan M. Recent developments in the management of neonatal hyperbilirubinemia. NeoReviews 1 2 (2000) e19-e24. http://neoreviews.aappublications.org/cgi/content/full/neoreviews;1/2/e1 9 Accessed June 27, 2008
148. Gottstein R., and Cooke R.W. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 88 1 (2003) F6-F10
149. Valaes T., Petmezaki S., Henschke C., et al. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics 93 1 (1994) 1-11
150. Martinez J.C., Garcia H.O., Otheguy L.E., et al. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 103 1 (1999) 1-5